Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply to "MuSK-Myasthenia Gravis and Cancer".
Falso S, Iorio R. Falso S, et al. Ann Neurol. 2024 Nov;96(5):1030-1031. doi: 10.1002/ana.27091. Epub 2024 Oct 4. Ann Neurol. 2024. PMID: 39363704 No abstract available.
Serological Markers of Clinical Improvement in MuSK Myasthenia Gravis.
Spagni G, Vincent A, Sun B, Falso S, Jacobson LW, Devenish S, Evoli A, Damato V. Spagni G, et al. Among authors: falso s. Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200313. doi: 10.1212/NXI.0000000000200313. Epub 2024 Sep 9. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39250722 Free PMC article.
Correction: Thymoma resection and myasthenia gravis: what is the neurological outcome in patients older than 65 years?
Lococo F, Sassorossi C, Maurizi G, Santoro G, Iorio R, Falso S, Meacci E, Napolitano AG, Congedo MT, Cusumano G, Trabalza Marinucci B, Argento G, Chiappetta M, Rendina EA, Margaritora S. Lococo F, et al. Among authors: falso s. Updates Surg. 2024 Oct;76(6):2503. doi: 10.1007/s13304-024-01954-9. Updates Surg. 2024. PMID: 39120860 Free PMC article. No abstract available.
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Howard JF Jr, Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Lowcock R, Vanderkelen M, Leite MI; RAISE Study Team. Howard JF Jr, et al. Lancet Neurol. 2023 May;22(5):395-406. doi: 10.1016/S1474-4422(23)00080-7. Lancet Neurol. 2023. PMID: 37059508 Clinical Trial.
Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab.
Damato V, Spagni G, Monte G, Scandiffio L, Cavalcante P, Zampetti N, Fossati M, Falso S, Mantegazza R, Battaglia A, Fattorossi A, Evoli A. Damato V, et al. Among authors: falso s. Neuromuscul Disord. 2023 Mar;33(3):288-294. doi: 10.1016/j.nmd.2023.02.005. Epub 2023 Feb 11. Neuromuscul Disord. 2023. PMID: 36842303 Free PMC article.
14 results